Fennec Pharmaceuticals (FENC) Other Non-Current Assets (2021 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Other Non-Current Assets came in at $717000.0 in Q4 2025, down 12.77% YoY from $822000.0 in Q4 2024, and down 3.5% on a QoQ basis from $743000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 5 years of Other Non-Current Assets data on file, last reported at $717000.0 in Q4 2025.
- Quarterly Other Non-Current Assets fell 12.77% year-over-year to $717000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $717000.0 (down 12.77% YoY) and the FY2025 annual result came in at $717000.0, down 12.77% from the prior year.
- Other Non-Current Assets eased to $717000.0 in Q4 2025, from $743000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.0 million in Q1 2024 to a low of $14000.0 in Q2 2022.
- A 5-year average of $526812.5 and a median of $730000.0 in 2025 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 833.02% — and 2025, when it slipped 22.35%.
- Tracing FENC's Other Non-Current Assets over 5 years: stood at $27000.0 in 2021, then surged by 681.48% to $211000.0 in 2022, then surged by 286.73% to $816000.0 in 2023, then increased by 0.74% to $822000.0 in 2024, then retreated by 12.77% to $717000.0 in 2025.
- The last three Other Non-Current Assets figures came in at $717000.0 (Q4 2025), $743000.0 (Q3 2025), and $768000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 666,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 666,000.00 |
| Dec 31, 2025 | 717,000.00 |
| Sep 30, 2025 | 743,000.00 |
| Jun 30, 2025 | 768,000.00 |
| Mar 31, 2025 | 794,000.00 |
| Dec 31, 2024 | 822,000.00 |
| Sep 30, 2024 | 956,000.00 |
| Jun 30, 2024 | 989,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 816,000.00 |
| Jun 30, 2023 | 106,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Dec 31, 2022 | 211,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 27,000.00 |